//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Online Registration is Open!
Register by Friday, January 23 to Save Up to $600!

Add to Outlook Calendar

Find Another IBC Event

Bioconjugates: From Targets to Therapeutics


Transitioning Innovation into Viable Therapeutic Candidates

May 18-20, 2015 | Parc 55 Wyndham | San Francisco, CA

Event Overview

Event Overview

Bringing Together Protein Engineers with Medicinal Chemists
in an Interdisciplinary Forum to Foster Innovation

From developing the platforms to create next generation ADCs to the evolution of nanoparticle conjugates, the bioconjugations landscape is rapidly evolving. IBC's 3 annual conference will bring together industry leaders and world-renowned academics, to provide you the latest updates on key topics including novel payloads, next generation ADCs and advances in the development lifecycle to allow you to improve your manufacturability and propel your therapeutic candidate toward commercial success.

Topics to be covered in 2015 include:

  • Novel Payload and Binding Techniques
  • Site-Specific Conjugation Methods and Strategies
  • Conjugated Vaccines
  • Beyond ADCs - Assessing Other Areas for Breakthroughs in Bioconjugates
  • Overcoming Challenges with Manufacturability
  • Conjugation Reaction and Characterizations
  • CMC Challenges and Regulatory Strategies

Now Accepting Speaker Submissions

Submit Now
Deadline to submit is December 17

Co-Located Events

10th Annual Next Generation Protein Therapeutics Summit
11th Annual Cell Line Development & Engineering

Together these 3 events give you access to this unique forum for the cross-fertilization of ideas to overcome your greatest challenges, from reducing risks to managing costs to expediting tight timelines, and, ultimately, propelling these promising candidates toward commercial success.

brochure cover

Brochure Now Available
» Download Today!